Ovarian cancer is a leading cause of cancer death in women and has a high mortality rate and a low 5-year survival rate (around 30%). Presentation is typically with late-stage metastatic disease which responds poorly to the conventional treatment of surgery and chemotherapy; most cancer deaths occur in women with high-grade serous ovarian carcinoma [1] . Screening tests employed before symptoms develop using either measurement of CA125 levels, ultrasound, or both have as yet not been proved effective in early detection. Despite extensive research the incidence of ovarian cancer is increasing and the survival rates have not improved significantly over the past decade [1] .
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Pelvic organ prolapse (POP) is the commonest indication for surgery in postmenopausal women and the commonest indication for hysterectomy [2] . Therefore, gynaecologists performing POP surgery are in a unique position to not only improve their patients' quality of life by treating their pelvic floor disorders but also decrease their risk of morbidity and mortality from ovarian cancer by offering prophylactic surgery.
Bilateral oophorectomy to prevent ovarian cancer in women having a hysterectomy for benign disease is commonplace. In the USA from 1998 to 2006, 39% of the 2,250,041 women who underwent hysterectomy for benign gynaecologic indications had elective bilateral salpingooophorectomy. However, this rate has been declining since 2002 [3] . A recent Australian survey found that over 60% of gynaecologists would recommend prophylactic oophorectomy in perimenopausal or postmenopausal women [4] .
Conventional teaching, particularly in the USA, has been that bilateral oophorectomy should be avoided in women younger than 40, routinely offered above 55, and considered in the 40 to 55 age group [5] . However, the trend is away from this approach, with ovarian conservation being preferred especially in the 40 to 55 age group. Recently the Royal Australian and New Zealand College of Obstetricians and Gynaecologists advised caution in performing prophylactic bilateral oophorectomy in women under 65 [4] . The postmenopausal ovary has a significantly diminished role in hormone production but still produces the androgens androstenedione and testosterone in significant amounts. Recent studies [6] have raised concerns regarding bilateral oophorectomy and the risk that early menopause may lead to premature death, cardiovascular and neurological disease, osteoporosis, and impaired psychological and sexual wellbeing. Also there is a natural reluctance for women to have both ovaries removed unless there is strong evidence of benefit.
Recent studies have improved our understanding of the pathogenesis of ovarian cancer and have opened up new opportunities for prevention, in which the pelvic floor surgeon will play an important role simply by performing bilateral salpingectomy at the time of POP surgery. There is increasing evidence that the majority of serous ovarian cancers do not come from the surface epithelium of the ovary, but rather arise from the distal fallopian tubes and subsequently spread to the ovary. Evidence for this first emerged in women with a BRCA1 mutation, who have a significant lifetime risk for developing ovarian cancer. When elective prophylactic bilateral salpingo-oophorectomies were performed to prevent this, histopathology showed the presence of tubal intraepithelial carcinoma in over 50% of patients [7, 8] . Tubal intraepithelial carcinoma has also been found in many women who previously would have been presumed to have ovarian or peritoneal serous cancer. Przybycin et al. [9] found that nearly 60% of high-grade pelvic nonuterine serous carcinomas were associated with serous tubal intraepithelial carcinoma. Molecular and genetic studies have provided further confirmatory evidence that high-grade serous cancers originate from the mucosa of the fallopian tubes rather than the surface of the ovaries; and that serous tubal intraepithelial carcinoma is the earliest form of carcinoma, rather than intraepithelial spread from adjacent invasive serous carcinoma of ovarian or peritoneal origin.
Therefore bilateral removal of the fallopian tubes rather than the ovaries may be just as effective in preventing ovarian cancer, and salpingectomy alone avoids issues of hormonal function. There is no debate that the fallopian tubes have no hormonal or biological value once reproduction is finished. Removal would therefore be appropriate at the time of pelvic surgery for prolapse or other benign pelvic conditions where there is surgical access to the fallopian tubes. Removal of the tubes at the time of vaginal hysterectomy or trans-vaginal prolapse repair can also usually be more easily performed than bilateral oophorectomy. This is especially true in the presence of pelvic adhesions and when the ovaries are adherent high on the pelvic sidewall, in which case bilateral oophorectomy can be difficult and sometimes impossible. Elective bilateral oophorectomy performed vaginally has been shown to have a higher rate of complications than the abdominal or laparoscopic approach [3] . Salpingectomy at the time of hysterectomy will also prevent the development of hydrosalpinx, which occurs in up to a third of women post hysterectomy when the fallopian tubes are conserved. Although hydrosalpinx usually does not cause clinical symptoms, it can lead to diagnostic confusion when pelvic ultrasound is performed.
The issue of salpingectomy and/or oophorectomy should be discussed with patients prior to surgery so that a consensual decision can be made. As always, a decision will need to be made on an individual basis and according to patient preference. Retaining ovarian function, particularly prior to menopause, will be more important in women with a personal or family history of cardiovascular or neurological disease, while bilateral salpingo-oophorectomy may be more appropriate in women with a higher risk of ovarian cancer.
